C12Y 114/18002
Cmp-n-acetylneuraminate monooxygenase
Official title: CMP-N-acetylneuraminate monooxygenase (1.14.18.2)
C12Y114/18002 (Cmp-n-acetylneuraminate monooxygenase) appears on 8 US grants and 13 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 13
- Assignees
- 10
- Inventors
- 31
- Latest grant
- 28 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 1 | 2 |
| 2014 | 1 | 1 |
| 2015 | 2 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 2 |
| 2022 | 0 | 2 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Identification of porcine xenoantigens28 Jan 2025US 12,207,629 B2Indiana University Research and Technology Corporation
- Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity15 Aug 2023US 11,725,044 B2Xenothera
- CRISPR/Cas9 vector combination and application thereof in gene knockout23 Nov 2021US 11,180,763 B2Nanjing Genefriend-Biotech Inc.
- Method of producing human-like glycosylation pattern using cells deficient in glutamine synthase, CMP-N-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase23 Jun 2015US 9,062,338 B1Sigma-Aldrich Co.
- Cells deficient in CMP-N-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase17 Mar 2015US 8,980,583 B2Sigma-Aldrich Co.
- Transgenic cloned pig for xenotransplantation expressing human cd46 and tbm genes, in which porcine endogenous retrovirus envelope c is negative and ggta1, cmah, igb3s and ß4galnt2 genes are knocked out, and method for preparing same11 Aug 2022US 2022/0248647 A1Optipharm Co., Ltd
- Identification of Porcine Xenoantigens16 Jun 2022US 2022/0183262 A1Indiana University Research and Technology Corporation
- Blood product derived from gene knockout pig and use thereof19 Aug 2021US 2021/0254004 A1Gcreatene (Suzhou) Biotechnology Co., Ltd.
- Crispr/cas9 vector combination and application thereof in gene knockout7 Jan 2021US 2021/0002652 A1Nanjing Genefriend-Biotech Inc.
- Identification of porcine xenoantigens1 Aug 2019US 2019/0230907 A1Indiana University Research and Technology Corporation
Most cited
By later US patents
- Transgenic mouse with a homozygous mutation in the CMAH gene12US 8,232,448 B2The Regents of the University of California · 2012
- Elimination of N-glycolylneuraminic acid from animal products for human use11US 8,541,231 B2The Regents of the University of California · 2013
- Elimination of N-glycolylneuraminic acid from animal products for human use3US 8,828,652 B2The Regents of the University of California · 2014
- Cells deficient in CMP-N-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase3US 8,980,583 B2Sigma-Aldrich Co. · 2015
- Method of producing human-like glycosylation pattern using cells deficient in glutamine synthase, CMP-N-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase1US 9,062,338 B1Sigma-Aldrich Co. · 2015